Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin

Nicotinic acid (NA) and fumaric acid esters (FAE) such as monomethyl fumarate or dimethyl fumarate are drugs that elicit a cutaneous reaction called flushing as a side effect. NA is used to reduce progression of atherosclerosis through its anti-dyslipidemic activity and lipid-independent mechanisms i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hanson, Julien (VerfasserIn) , Gille, Andreas (VerfasserIn) , Offermanns, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 June 2012
In: Pharmacology & therapeutics
Year: 2012, Jahrgang: 136, Heft: 1, Pages: 1-7
ISSN:1879-016X
DOI:10.1016/j.pharmthera.2012.06.003
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.pharmthera.2012.06.003
Verlag, Volltext: http://linkinghub.elsevier.com/retrieve/pii/S0163725812001210
Volltext
Verfasserangaben:Julien Hanson, Andreas Gille, Stefan Offermanns

MARC

LEADER 00000caa a2200000 c 4500
001 1577987993
003 DE-627
005 20230426230754.0
007 cr uuu---uuuuu
008 180726s2012 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.pharmthera.2012.06.003  |2 doi 
035 |a (DE-627)1577987993 
035 |a (DE-576)507987993 
035 |a (DE-599)BSZ507987993 
035 |a (OCoLC)1341014540 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hanson, Julien  |e VerfasserIn  |0 (DE-588)1163417769  |0 (DE-627)1027793657  |0 (DE-576)507987780  |4 aut 
245 1 0 |a Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin  |c Julien Hanson, Andreas Gille, Stefan Offermanns 
264 1 |c 26 June 2012 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist die Zahl 2 tiefgestellt 
500 |a Available online 26 June 2012 
500 |a Gesehen am 26.07.2018 
520 |a Nicotinic acid (NA) and fumaric acid esters (FAE) such as monomethyl fumarate or dimethyl fumarate are drugs that elicit a cutaneous reaction called flushing as a side effect. NA is used to reduce progression of atherosclerosis through its anti-dyslipidemic activity and lipid-independent mechanisms involving immune cells, whereas FAE are used to treat psoriasis via largely unknown mechanisms. Both, NA and FAE, induce flushing by the activation of the G-protein-coupled receptor (GPCR) Hydroxy-carboxylic acid receptor 2 (HCA2, GPR109A) in cells of the epidermis. While the wanted effects of NA are at least in part also mediated by HCA2, it is currently not clear whether this receptor is also involved in the anti-psoriatic effects of FAE. The HCA2‐mediated flushing response to these drugs involves the formation of prostaglandins D2 and E2 by Langerhans cells and keratinocytes via COX-1 in Langerhans cells and COX-2 in keratinocytes. This review summarizes recent progress in the understanding of the mechanisms underlying HCA2-mediated flushing, describes strategies to mitigate it and discusses the potential link between flushing, HCA2 and the anti-psoriatic effects of FAE. 
700 1 |a Gille, Andreas  |e VerfasserIn  |0 (DE-588)1067222081  |0 (DE-627)818452242  |0 (DE-576)426483618  |4 aut 
700 1 |a Offermanns, Stefan  |d 1964-  |e VerfasserIn  |0 (DE-588)113037279  |0 (DE-627)584488734  |0 (DE-576)289750113  |4 aut 
773 0 8 |i Enthalten in  |t Pharmacology & therapeutics  |d Amsterdam [u.a.] : Elsevier Science, 1979  |g 136(2012), 1, Seite 1-7  |h Online-Ressource  |w (DE-627)306661330  |w (DE-600)1500663-3  |w (DE-576)081986904  |x 1879-016X  |7 nnas  |a Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin 
773 1 8 |g volume:136  |g year:2012  |g number:1  |g pages:1-7  |g extent:7  |a Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin 
856 4 0 |u http://dx.doi.org/10.1016/j.pharmthera.2012.06.003  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://linkinghub.elsevier.com/retrieve/pii/S0163725812001210  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180726 
993 |a Article 
994 |a 2012 
998 |g 113037279  |a Offermanns, Stefan  |m 113037279:Offermanns, Stefan  |d 700000  |d 718000  |e 700000PO113037279  |e 718000PO113037279  |k 0/700000/  |k 1/700000/718000/  |p 3  |y j 
998 |g 1067222081  |a Gille, Andreas  |m 1067222081:Gille, Andreas  |d 60000  |d 65400  |e 60000PG1067222081  |e 65400PG1067222081  |k 0/60000/  |k 1/60000/65400/  |p 2 
999 |a KXP-PPN1577987993  |e 3019609593 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"7 S."}],"relHost":[{"title":[{"title_sort":"Pharmacology & therapeutics","subtitle":"an international review journal","title":"Pharmacology & therapeutics"}],"titleAlt":[{"title":"Pharmacology and therapeutics"}],"part":{"year":"2012","pages":"1-7","issue":"1","volume":"136","text":"136(2012), 1, Seite 1-7","extent":"7"},"pubHistory":["Nachgewiesen 4.1979 -"],"language":["eng"],"recId":"306661330","disp":"Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skinPharmacology & therapeutics","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 19.02.20"],"id":{"issn":["1879-016X"],"eki":["306661330"],"zdb":["1500663-3"]},"origin":[{"dateIssuedKey":"1979","publisher":"Elsevier Science","dateIssuedDisp":"1979-","publisherPlace":"Amsterdam [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Julien Hanson, Andreas Gille, Stefan Offermanns"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"26 June 2012"}],"id":{"doi":["10.1016/j.pharmthera.2012.06.003"],"eki":["1577987993"]},"note":["Im Titel ist die Zahl 2 tiefgestellt","Available online 26 June 2012","Gesehen am 26.07.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1577987993","person":[{"role":"aut","display":"Hanson, Julien","roleDisplay":"VerfasserIn","given":"Julien","family":"Hanson"},{"family":"Gille","given":"Andreas","display":"Gille, Andreas","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Offermanns","given":"Stefan","display":"Offermanns, Stefan","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin","title_sort":"Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin"}]} 
SRT |a HANSONJULIROLEOFHCA22620